Deccan Health Care logo

Deccan Health Care financials and balance sheet

BSE: 542248Healthcare ServicesSmall Cap

Last close ₹11.93down ₹0.80 (6.28%)

Share price at the BSE close on 23 Oct 2026. Previous close ₹12.73.

52-week range of traded prices to 23 Oct 2026
₹6.65Low, 30 Mar 2026₹18.40High, 3 Nov 2025
Market cap
₹29 Cr3,846th largest listed
P/E
11.3
P/B
0.3
Dividend yield
Nonein the last 12 months
ROE
2.3%
ROCE
3.3%
Debt to equity
0.04
Volume, BSE
2,050

8 years at a glance

Standalone: the listed company alone, without its subsidiaries. ₹ crore, years to March.Deccan Health Care annual reports

Revenue, net profit and borrowings, ₹ crore

  • Revenue
  • Net profit
  • Borrowings
Peak revenue ₹89 Cr, year to Mar 2026

Operating and net margin, per cent

  • Operating margin
  • Net margin

Results for the year to Mar 2026

Standalone: the listed company alone, without its subsidiaries. ₹ crore.

From revenue to net profit

  1. Revenue89
  2. Materials and goods−61
  3. Employee costs−5.2
  4. Other expenses−18
  5. Operating profit4.9
  6. Depreciation−1.5
  7. Other income0.0
  8. One-off items0.0
  9. Finance costs−0.4
  10. Profit before tax3.1
  11. Tax−0.8
  12. Net profit2.3

What the company owns

  • Plant, investments and other assets₹79 Cr
  • Inventory₹40 Cr
  • Receivables₹24 Cr
  • Cash and bank₹2 Cr

What pays for it: net worth and liabilities

  • Net worth₹110 Cr
  • Owed to suppliers₹17 Cr
  • Other liabilities₹13 Cr
  • Borrowings₹4 Cr

Profit and loss

Standalone, ₹ crore, years to March.Deccan Health Care quarterly results

₹ croreMar 2019Mar 2020Filed 6 AugMar 2021Mar 2022Filed 16 JunMar 2023Filed 31 MayMar 2024Filed 2 AugMar 2025Filed 13 JunMar 2026Filed 30 May
Revenue from operations44.242.233.833.245.059.775.189.2
27.4–31.7–42.956.071.984.3
Materials and goods bought15.116.718.414.325.037.547.660.6
Employee costs4.1–2.9–3.23.44.35.2
Other expenses8.2–10.4–14.815.120.018.4
Operating profit before depreciation16.8–2.0–2.13.83.24.9
Operating margin38.0%–6.0%–4.7%6.3%4.2%5.5%
Materials, % of revenue34.2%–54.6%–55.5%62.7%63.3%68.0%
Employee costs, % of revenue9.2%–8.6%–7.0%5.7%5.8%5.9%
Other expenses, % of revenue18.6%–30.8%–32.8%25.2%26.6%20.6%
Depreciation and amortisation1.3–1.51.51.41.51.51.5
Operating profit after depreciation15.5–0.6–0.72.31.73.4
Other income0.10.10.10.20.00.00.00.0
Finance costs1.00.20.10.20.10.10.10.4
Profit before one-off items and tax14.610.10.53.90.62.21.73.1
One-off items–––––0.00.00.0
Profit before tax14.610.10.50.50.62.21.73.1
0.10.00.10.20.20.70.50.8
Net profit14.510.10.40.30.51.51.22.3
Other comprehensive income–––––0.00.20.0
Total comprehensive income–––––1.51.42.3
Net margin32.7%23.9%1.2%1.0%1.0%2.5%1.6%2.6%
Operating expenses, operating profit before depreciation and operating profit after depreciation are left blank for the year to Mar 2020: the statement does not state its depreciation, which operating profit is worked out from, so operating profit is not given. Operating expenses, operating profit before depreciation and operating profit after depreciation are left blank for the year to Mar 2022: revenue, other income and exceptional items less the total expenses stated do not come to the profit before tax the same statement states, so the operating expenses cannot be told apart from the rest.

Balance sheet

Standalone, ₹ crore, at 31 March.

₹ croreMar 2020Filed 6 AugMar 2021Mar 2022Filed 16 JunMar 2023Filed 31 MayMar 2024Filed 2 AugMar 2025Filed 13 JunMar 2026Filed 30 May
76–778297107110
Share capital16–1617202325
Reserves61–6165778385
1–10114
14–101271529
3–33335
Total assets93–9197107124144
27–2321201919
66–687687105125
Net debt−3–−2−1−1−22
Borrowings are counted again inside the liabilities due within a year and after a year. No balance sheet is on record for the years to Mar 2019 and Mar 2021, so its lines and the ratios worked from it are blank there.

Cash flow

Standalone, ₹ crore, years to March.

₹ croreMar 2022Filed 16 JunMar 2023Filed 31 MayMar 2024Filed 2 AugMar 2025Filed 13 JunMar 2026Filed 30 May
−0.6−5.8−12.5−6.6−3.6
−0.3−5.6−11.6−6.5−3.6
−2.5−7.0−15.4−9.6−8.7
Receivables−0.40.82.1−2.7−11.1
Inventories−1.5−0.31.13.22.8
Payables0.12.7−4.24.77.6
Other working capital−0.7−10.2−14.4−14.8−8.0
Tax paid−0.3−0.2−0.90.00.0
Interest paid0.00.00.00.10.0
Capital spending0.10.00.30.02.6
Free cash flow−0.7−5.8−12.8−6.6−6.2
0.00.3−0.30.0−2.2
0.14.313.67.94.0
Dividends paid0.00.00.00.00.0
Shares bought back––0.00.00.0
Shares issued0.05.013.98.51.4
Net change in cash−0.6−1.30.91.3−1.9
Capital spending is part of cash from investing, and dividends paid, shares bought back and shares issued are part of cash from financing. Each is shown as an amount on a line of its own, and the section's other items are in its total only. No cash flow statement is on record for the years to Mar 2019, Mar 2020 and Mar 2021.

Per share

Standalone, ₹ per share, years to March.

₹ per shareMar 2019Mar 2020Filed 6 AugMar 2021Mar 2022Filed 16 JunMar 2023Filed 31 MayMar 2024Filed 2 AugMar 2025Filed 13 JunMar 2026Filed 30 May
Earnings per share₹10.29₹6.42₹0.25₹0.21₹0.27₹0.82₹0.56₹0.93
Diluted earnings per share₹10.29₹6.42₹0.25₹0.21₹0.27₹0.82₹0.47₹0.93
Book value per share–₹48.51–₹48.97₹47.91₹47.62₹45.49₹44.54
Shareholder yield–––0.0%−11.6%−24.6%−22.1%−8.1%
Market cap at the year end (₹ crore)16843465643563817

Ratios

Standalone, years to March.Deccan Health Care PE ratio and valuation

RatioMar 2019Mar 2020Filed 6 AugMar 2021Mar 2022Filed 16 JunMar 2023Filed 31 MayMar 2024Filed 2 AugMar 2025Filed 13 JunMar 2026Filed 30 May
Revenue growth–−4.5%−20.0%−1.8%35.7%32.7%25.8%18.7%
Operating profit growth–––––76.6%−15.1%52.9%
Net profit growth–−30.3%−96.1%−16.9%40.6%234.0%−21.3%91.2%
Earnings per share growth–−37.6%−96.1%−16.0%28.6%203.7%−31.7%66.1%
–13.2%–0.4%0.6%1.7%1.2%2.1%
––––0.2 pts1.1 pts−0.5 pts0.9 pts
From the net margin––––0.0 pts0.9 pts−0.6 pts0.7 pts
From asset turnover––––0.1 pts0.3 pts0.1 pts0.0 pts
From borrowing––––0.0 pts−0.1 pts0.0 pts0.2 pts
Return on capital employed––––0.9%2.3%1.6%3.0%
Cash conversion–––−176.6%−1,283.2%−820.2%−550.3%−156.6%
Interest cover15.0–5.3–6.436.123.59.3
Debt to equity–0.01–0.010.000.010.010.04
Receivable days–178–14198606197
Inventory days–826–1,183683445326239
Payable days–––––416899
Cash conversion cycle, days–––––464319237
Working capital days–422–603501479425390
Asset turnover–0.45–0.370.480.590.650.67
Assets per rupee of net worth–1.22–1.181.181.141.141.24
Sales per rupee of plant–1.99–1.792.673.815.235.95
Capital spending to depreciation–––0.080.000.210.001.75
Plant being built, % of plant in use–––––0.0%0.0%0.0%
No balance sheet is on record for the years to Mar 2019 and Mar 2021, so its lines and the ratios worked from it are blank there.

Growth and returns over 3, 5 and 10 years

Standalone: the listed company alone, without its subsidiaries. Each window ends with the year to Mar 2026.

Return on assets, latest year
1.7%
Cash from operations against operating profit
−73.6%
Measure5 years3 years
Revenue growth, yearly rate21.4%25.6%
Profit growth, yearly rate42.5%71.3%
Return on equity, average1.2%1.7%
Return on capital employed, average1.9%2.3%
Operating margin, average5.2%5.3%
Net margin, average1.7%2.2%
Asset turnover, average0.550.63
Cash conversion cycle, days, average–340
Interest cover, average18.823.0
Debt to equity, average0.020.02

Where the cash came from and went

Standalone: the listed company alone, without its subsidiaries. ₹ crore, added up over each window, which ends with the year to Mar 2026.

₹ crore5 years3 yearsLatest year
Cash from operations−29.1−22.7−3.6
Cash from investing−2.4−2.6−2.2
Cash from financing29.925.54.0
Capital spending3.02.92.6
Dividends paid0.00.00.0
Shares bought back–0.00.0
Shares issued for cash28.723.71.4
Borrowings raised3.83.83.3
Borrowings repaid2.31.50.4

Accounting checks

Standalone, years to March. Published tests of whether reported profit is backed by cash and the balance sheet.

CheckMar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Effective tax ratePublished threshold 17.16 per cent0.590.44––––––
A threshold marked as ours has no published figure; it is the line we read the check against.